Skip to main content

Animations

MJFF Publications

8341 - 8350 of 9131 Results
Title
Year
  • Year
  • 2024
  • 2025
  • 2024
  • 2025
  • 2024
  • 2026
  • 2026
  • 2026
  • 2024
  • 2026
  • Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease
    2024
    Summary Details
    RESTRICTED
    Title: Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.4c00602
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The interplay between stress, inflammation and Parkinson’s disease: insights from the COVID-19 pandemic
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-01178-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2024.105065
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian Monkeys
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30280
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐Berbers
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29735
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Development of cannabinoid-based therapies for Parkinson’s disease: emphasis on targeting cannabinoid receptors as CB2, PPAR-γ and GPR55 receptors
    Journal Name: Molecular Neurodegeneration Advances
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s44477-025-00016-7
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohort
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x261431204
    Citation Count: 0
  • Summary Details
    OPEN
    Title: DeepFaceMouse enables scalable prediction of large-scale brain activity from facial dynamics in mice
    Journal Name: Cell Reports Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.crmeth.2026.101480
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Bacteroides acidifaciens: Linking dietary fiber to liver health
    Journal Name: Cell Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cmet.2024.08.002
    Citation Count: 7
  • Summary Details
    OPEN
    Title: STN ‐ DBS : Pre‐Synaptic Stimulation Causes Post‐Synaptic Inhibition
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70217
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.